WO2007119557A1 - Method of detecting koi herpes virus (khv) - Google Patents

Method of detecting koi herpes virus (khv) Download PDF

Info

Publication number
WO2007119557A1
WO2007119557A1 PCT/JP2007/056614 JP2007056614W WO2007119557A1 WO 2007119557 A1 WO2007119557 A1 WO 2007119557A1 JP 2007056614 W JP2007056614 W JP 2007056614W WO 2007119557 A1 WO2007119557 A1 WO 2007119557A1
Authority
WO
WIPO (PCT)
Prior art keywords
khv
dna
seq
sequence
koi
Prior art date
Application number
PCT/JP2007/056614
Other languages
French (fr)
Japanese (ja)
Inventor
Takashi Aoki
Ikuo Hirono
Original Assignee
National University Corporation Tokyo University Of Marine Science And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University Corporation Tokyo University Of Marine Science And Technology filed Critical National University Corporation Tokyo University Of Marine Science And Technology
Priority to JP2008510874A priority Critical patent/JP5315519B2/en
Publication of WO2007119557A1 publication Critical patent/WO2007119557A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Definitions

  • KHV koi herpesvirus
  • the present invention relates to a koi herpes virus detection primer set and a koi herpes virus detection probe capable of identifying a pathogen of koi herpes virus (KHV) infecting carp, and a primer set and a probe thereof.
  • the present invention relates to a method for detecting koi herpes virus used. Background art
  • Koi herpesvirus disease is a disease caused by koi herpes virus (KHV) and caused by Magyi and Shikigoi.
  • KHV koi herpes virus
  • Magyi and Shikigoi The external symptoms are small carp fading and erosion (soak), which occurs from juveniles to adults, and is a carp disease with a high mortality rate.
  • a primer for virus detection simply provides type-specific detection methods for herpesvirus type I and type II, which are large enough to allow chemical synthesis, and that By using DNA primers and probes consisting of base sequences that do not reduce other specificity, HSVI or HSVII infections can be identified with high accuracy, speed, and type-specificity.
  • a nucleic acid that can be used for diagnosing a method that can use the results for diagnosis and treatment see, for example, Patent Document 1 and human immunodeficiency virus (HIV) infection that causes AIDS.
  • Nucleotide sequences that can be used as primers and probes for amplification and detection of nucleic acids see, for example, Patent Document 2
  • Nucleotide sequences that can be used as primers and probes for amplification and detection of nucleic acids see, for example, Patent Document 2
  • a method for detecting a winding virus (TY LCV) with high sensitivity for example, refer to Patent Document 3
  • TY LCV winding virus
  • Patent Document 3 a nucleic acid primer containing a part of a broad bean Wilt virus RNA or a DNA in which uracil is replaced with thymine in the base sequence
  • a method for detecting a broad bean virus using a nucleic acid primer containing a part of a nucleic acid having complementarity with RNA of broad bean virus see, for example, Patent Document 4).
  • Non-Patent Document 1 a detection method for koi herpesvirus that detects DNA with a length of 292 bp by PCR (for example, see Non-Patent Document 1) has been reported, but problems have been pointed out in terms of detection sensitivity and accuracy. It has been.
  • Patent Document 1 Japanese Patent Laid-Open No. 5-56800
  • Patent Document 2 Japanese Patent Publication No. 2001-512701
  • Patent Document 3 Japanese Patent Application Laid-Open No. 2004-215520
  • Patent Document 4 Japanese Patent Laid-Open No. 11-313679
  • Patent Document 5 Japanese Patent Laid-Open No. 7-284399
  • Non-patent literature l Yuasa, K. et.al. (2005) Fish Pathology 40 (1): 37-39.
  • Koi herpesvirus disease has a high fatality rate.
  • Koi herpes virus disease has caused enormous damage not only to farmed carp but also to natural carp inhabiting lakes.
  • An object of the present invention is to provide a primer set for detecting koi herpes virus, a probe for detecting koi herpes virus, a probe for detecting koi herpes virus, a primer set for detecting koi herpes virus, a primer set of these,
  • An object of the present invention is to provide a method for detecting koi herpesvirus using a probe.
  • the present inventors have intensively studied, determined the entire base sequences of koi herpesvirus genes in Japan, the United States, Israel, and Indonesia, and at the level of each koi herpesvirus gene. It was confirmed that the homology was about 99% and the homology at the amino acid level was about 100%. Next, among the elucidated all nucleotide sequences, paying attention to the repetitive sequence portion specific to the koi herpesvirus pathogen, the known eukaryotes and viruses differ.
  • the present invention relates to (1) a first DNA primer containing an oligonucleotide part of at least 10 bases in the base sequence shown in SEQ ID NO: 1 in the sequence listing, and SEQ ID NO: 2 in the sequence listing.
  • a primer set for detecting koi herpesvirus comprising a second DNA primer containing an oligonucleotide portion of at least 10 bases of the base sequence shown in (2) A first DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 3 and a first DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 4 in the sequence listing;
  • a primer set for detection of koi herpesvirus characterized by comprising two DNA primers, and (3) the above-mentioned (1) or (2)
  • a detection method for koi herpesvirus (KHV) characterized by amplifying koi herpesvirus (KHV) gene in a test sample using a primer set for detecting herpes virus (KHV), ( 4) A koherpesvirus (KHV) detection probe comprising a labeled oligonucleot
  • the present invention also relates to (7) DNA having the nucleotide sequence shown in SEQ ID NO: 5 or 6 or a complementary sequence thereof, or (8) one or several nucleotides in the nucleotide sequence shown in SEQ ID NO: 5 or 6. Consisting of a base sequence deleted, substituted, or added, and used as a probe And DNA that can detect koi herpesvirus (KHV) and (9) DNA that has a sequence ability complementary to the nucleotide sequence shown in SEQ ID NO: 5 or 6 under stringent conditions. It also relates to DNA that can detect koi herpesvirus (KHV) when used as a probe.
  • KHV koi herpesvirus
  • -I is a graph showing the total length (bp) of the KHV genome and the predicted number of genes.
  • FIG. 2 is a diagram showing the results of comparing the homology of KHV genomes of Japanese isolates (KHV-J), American isolates (KHV-A), and Israel isolates (KHV-I).
  • FIG. 3 is a diagram showing the results of electrophoresis of PCR amplification products using the KHV detection primer of the present invention.
  • FIG. 4 is a diagram showing the results of electrophoresis of PCR amplification products for the amount of KHV genome (six types) using the KHV disease pathogen detection primer of the present invention.
  • FIG. 5 is a diagram showing the results of electrophoresis of PCR amplification products for DNA of 3 carp pupae infected with KHV using the KHV disease pathogen detection primer of the present invention.
  • a primer set for detection of koi herpesvirus (KHV) of the present invention a first DNA primer containing an oligonucleotide portion of at least 10 bases of the base sequence shown in SEQ ID NO: 1 in the sequence listing; A primer set comprising a second DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 2 in the sequence listing, or of the base sequence shown in SEQ ID NO: 3 in the sequence listing A first DNA primer containing an oligonucleotide portion of at least 10 bases;
  • the primer set is not particularly limited as long as it is a primer set comprising a second DNA primer containing an oligonucleotide at least 10 nucleotides of the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing, and for detecting these koi herpes viruses.
  • a primer set comprising a second DNA primer containing an oligonucleotide at least 10 nucleotides of the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing, and for detecting these koi herpes viruses.
  • the second DNA primer is preferably a primer containing an oligonucleotide part of 10 to 50 bases, more preferably an oligonucleotide part of 15 to 30 bases, and more preferably an oligonucleotide part of 20 bases.
  • the DNA to be amplified by PCR should be at least one base away!
  • the koi herpesvirus (KHV) detection probe of the present invention includes the nucleotide sequence shown in SEQ ID NO: 5 in the sequence listing (the koi herpes virus genome is 7689-7878! 280527-280716 of 190 bp) or a probe having a labeled oligonucleotide portion of at least 10 bases, preferably 20 bases or more of IJ, or shown in SEQ ID NO: 6 in the sequence listing Probes having a labeled nucleotide sequence of at least 10 bases, preferably 20 bases or more, or a complementary sequence thereof (the 165 bp portion of koi herpesvirus genome 15 996-16160 or 288834-288998) or its complementary sequence
  • the probe is not particularly limited as long as it has a pH, and the koi herpesvirus detection probe and the test sample are incubated under conditions where hybridization is possible. By Tosuru, it can be detected by a conventional method Koiheru
  • the test sample is not particularly limited as long as it is a sample suspected of containing koi herpes virus.
  • it is usually obtained from tissues and blood such as carp era, epidermis, liver, and kidney.
  • a DNA extract extracted by the method can be specifically exemplified.
  • the method for detecting koi herpesvirus of the present invention using the koi herpes virus detection primer set of the present invention comprises an amplification process of koi herpes virus gene DNA in a test sample, koi herpes virus gene DN A detection process.
  • the gene DNA amplification process the polymerase chain reaction (PCR) method, the loop-mediated 'isothermal' amplification method (LAMP), the isothermal 'and'chimeric'primer-cited amplification method ( ICAN) can be used.
  • PCR polymerase chain reaction
  • LAMP loop-mediated 'isothermal' amplification method
  • ICAN isothermal 'and'chimeric'primer-cited amplification method
  • the PCR method can automatically amplify only the target DNA region up to about 1 million times from a very small amount of DNA (Science, 239: 487-491, 1988).
  • a primer for the sense strand hereinafter sometimes referred to as the first primer
  • a primer for the antisense strand hereinafter sometimes referred to as the second primer
  • Gene DNA can be amplified.
  • Each base constituting each of the first primer and the second primer may be modified in any known manner (for example, labeled with piotin or a luminescent substance).
  • the amplification cycle is repeated using a DNA polymerase, preferably a heat-resistant DNA polymerase, together with the first primer and the second primer.
  • a DNA polymerase preferably a heat-resistant DNA polymerase
  • the thermostable polymerase it is preferable to use DNA polymerase capable of maintaining activity at a temperature up to 95 ° C., for example, Taq polymerase available from the market.
  • the amounts used of the first primer, the second primer, and the DNA polymerase vary depending on the type of test sample, but can be easily determined as long as the DNA amplification step by the PCR method can be performed.
  • the mixture can optionally contain a buffer (eg, Tris-HCl buffer), a stabilizer (eg, gelatin), or a salt (eg, sodium chloride).
  • Amplification conditions when PCR is performed using a mixed solution containing the primer set of the present invention, DNA polymerase and test sample are, for example, DNA denaturation (about 90 to 95 ° C, about 10 seconds to about About 2 minutes), annealing of single-stranded DNA with the first and second primers (about 37-70 ° C, about 30 seconds to about 3 minutes), and DNA synthesis with DNA polymerase (about 65-80 ° C) C for about 30 seconds to about 5 minutes) can be preferably mentioned, and this amplification cycle is preferably repeated 10 to 60 times, particularly 20 to 40 times. In the final cycle, it is preferable to extend the DNA synthesis heating time by DNA polymerase to about 5 to: LO minutes to ensure complete DNA synthesis! /. If koi herpesvirus is present in the test sample, a large amount of koi herpesvirus-derived DNA will be synthesized after the amplification cycle, and this DNA will be detected in the next DNA detection step.
  • a method using gel electrophoresis and ethidium bromide staining, a Southern plot hybrid method, a base sequencing method by the dideoxy method, a radioactive labeling method, or the like may be used. it can.
  • a method using gel electrophoresis and ethidium bromide staining, a Southern plot hybrid method, a base sequencing method by the dideoxy method, a radioactive labeling method, or the like may be used. it can.
  • submarine type electrophoresis using an agarose gel as a carrier or slab type electrophoresis using acrylamide can be used.
  • a radioactive probe or a non-radioactive probe for example, an enzyme-labeled probe, a piotinylated probe, a digoxigenated probe, a chemiluminescent substance, or a probe labeled with a fluorescent substance
  • a DNA autosequencer Applied Biosystems
  • a fluorescent label can be used.
  • an oligonucleotide having a base sequence (acagtgtccgacttgtgcga) shown in SEQ ID NO: 1 (hereinafter sometimes referred to as KHV-TNFR-F)
  • KHV-TNFR-F an oligonucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 2 (tggtgc ccacatgtgcgttg)
  • KHV—TNFR—R hereinafter sometimes referred to as KHV—TNFR primer set
  • KHV-GT-F oligonucleotide having the base sequence shown in SEQ ID No. 4 (gaatccat ccccatcacccg)
  • KHV-GT primer set oligonucleotide having the base sequence shown in SEQ ID No. 4
  • KHV-GT oligonucleotide having the base sequence shown in SEQ ID No. 4
  • R oligonucleotide having the base sequence shown in SEQ ID No. 4
  • R oligonucleotide having the base sequence shown in SEQ ID No. 4
  • KHV-GT primer set oligonucleotide having the base sequence shown in SEQ ID No. 4
  • R oligonucleotide having the base sequence shown in SEQ ID No. 4
  • R oligonucleotide having the base sequence shown in SEQ ID No. 4
  • KHV-GT primer set oligonucleotide having the base sequence shown in SEQ ID No. 4
  • the KHV-TNFR-F is present in the koi herpesvirus genome 7689-7708 or 2 80527-280546, and the KHV-TNFR-R is the koi herpesvirus genome 7 859-7878! / ⁇ 280697— 280716 [This is a double strand of J. Using these HV-TNFR primer sets, it is possible to amplify DNA with a nucleotide sequence of 190 bp shown in SEQ ID NO: 5. Can do. In addition, the above KHV-GT-F has the genome of koi herpes innores 15996-16015!
  • KHV-GT-R is the genome of koi herpesvirus 16141-16160 or It is a complementary strand of the sequence present in 288979-288998.
  • KHV-GT primer sets a DNA having a base sequence of 165 bp shown in SEQ ID NO: 6 can be amplified.
  • the 190bp portion of the Coherenovirus virus 7689-7878 or 280527-280716 is the genome 15996-16160!
  • the first primer and the second primer of the present invention can be prepared by a known DNA synthesis method (for example, phosphoramidite method) using an ordinary automatic DNA synthesizer (for example, manufactured by Ablide Biosystems). it can.
  • the method for detecting koi herpesvirus of the present invention using the probe for detecting koi herpes virus of the present invention is the method of detecting the koi herpes virus gene DNA in the test sample.
  • a probe for detecting koi herpesvirus can be detected by detecting the labeling substance bound to the probe. From the sample suspected of containing koi herpes virus, A DNA extract extracted by a conventional method can be used as it is. Koi herpesvirus gene DNA amplified by the PCR method can also be used.
  • labeling substance examples include enzymes, fluorescent substances, chemiluminescent substances, radioisotopes, piotin, avidin, and the like. Specifically, peroxidase (for example, horseradish peroxidase), anorecalphosphatase, etc.
  • ⁇ -D galactosidase glucose oxidase, glucose 6-phosphate dehydrogenase, alcohol dehydrogenase, malate dehydrogenase, percylinase, catalase, apoglucose oxidase, urease, luciferase or acetylcholinesterase
  • Fluorescent substances such as cein isothiocyanate, phycopyriprotein, rare earth metal chelates, dansyl chloride or tetramethylrhodamine isothiocyanate, radioactive isotopes such as 3 H, “C, 125 I or 131 1, piotin, Examples of vidin or chemiluminescent materials can be given.
  • the DNA of the present invention includes a DNA consisting of the base sequence shown in SEQ ID NO: 5 or 6 or a complementary sequence thereof, or the base sequence shown in SEQ ID NO: 5 or 6, lacking one or several bases.
  • base sequence in which one or several bases are deleted, substituted or added is not particularly limited, for example, 1 to 20, preferably 1 to 15, more preferably 1 to: LO means a base sequence in which any number of bases, more preferably 1 to 5, is deleted, substituted or added.
  • DNA consisting of a base sequence in which one or several bases are deleted, substituted or added is known to those skilled in the art such as chemical synthesis, genetic engineering techniques, mutagenesis, etc. It can also be produced by any method. Specifically, the DNA having the nucleotide sequence shown in SEQ ID NO: 5 or 6 can be contacted with a mutagen drug, irradiated with ultraviolet light, genetically engineered, etc. Mutant DNA can be obtained by introducing mutations into these DNAs. Site-specific mutagenesis, one of the genetic engineering methods, is a technique that can introduce a specific mutation at a specific position.
  • base sequence that hybridizes under stringent conditions means using a nucleic acid such as DNA or RNA as a probe, colony 'hybridization method, plaque hybridization method, Alternatively, it means a base sequence obtained by using the Southern blot hybridization method, etc., specifically, using a filter on which colony or plaque-derived DNA or a fragment of the DNA is immobilized.
  • SSC solution the composition of the SSC solution with 1 concentration is 150 mM salt solution
  • DNA that can be identified can be raised by washing the filter at 65 ° C with sodium chloride (15 mM sodium citrate).
  • Hybridization can be carried out according to the method described in Molecular Cloning 3rd edition.
  • DNA that can be hybridized under stringent conditions includes DNA having a certain degree of homology with the base sequence of the DNA used as a probe, for example, 60% or more, preferably 70%.
  • a DNA having a homology of at least%, more preferably at least 80%, further preferably at least 90%, particularly preferably at least 95%, most preferably at least 98% can be suitably exemplified.
  • the method for obtaining and preparing the DNA of the present invention is not particularly limited, and the KHV-TNFR primer set and the KHV-GT primer set disclosed in the present specification are prepared, and they are used to produce a koihelpe. Screening the DNA library of the virus (KHV) The target DNA can be isolated from this or prepared by chemical synthesis according to conventional methods.
  • CTABZNaCl solution 10% cetyltrimethylammonium oxalic acid solution containing 0.7M NaCl
  • Tris trishydroxymethylaminomethane
  • trishydrochloric acid trishydroxymethylaminomethane
  • SDS sodium dodecyl sulfate
  • EDTA ethylenediamine tetraacetic acid
  • TBE buffer 0.089M bis, 0.089M boric acid, liquid containing 0.002M EDTA
  • BSA sushi serum albumin
  • TE 10 mM Tris-HCl (pH 8.0), ImM EDTA (pH 8.0) -containing solution
  • dATP Deoxyadenosine triphosphate
  • dCTP Deoxycytosine triphosphate
  • dGTP Deoxyguanine triphosphate
  • dTTP Deoxythymine triphosphate
  • Triton X-100 Polyoxyethylene (10) octylphenolate
  • KHV isolated from carp in Japan, USA and Israel namely Japanese isolate (D DBJ accession number; AP008984), American isolate (DDBJ accession number; D Q657948) and Israel isolate (DDBJ The entire genomic sequence of the accession number; DQ 177346) was determined.
  • Figure 1 shows the total length (bp) of these KHV genomes and the predicted number of genes
  • Figure 2 shows the results of comparing the homology of these KHV genomes.
  • the following 2 sets of PCR primers were prepared from these KHV genome sequences.
  • the position of each primer in the genome of the Japanese isolate (KHV-J) is shown.
  • KHV ⁇ TNFR ⁇ F 5 ⁇ acagtgtccgacttgtgcga ⁇
  • KHV-TNFR— R 5, — tggtgcccacatgtgcgttg-3,
  • the following sequence 190 bp is amplified by the KHV—TNFR primer.
  • the underline indicates the primer sequence.
  • the following sequence 165 bp is amplified by the KHV-GT primer.
  • the underline indicates the primer sequence.
  • Genomic DNA extraction of KHV was performed according to Molecular Cloning 3rd edition. The extracted DNA was dialyzed against TE buffer.
  • KHV-TNF R-F which is the 7708th sequence
  • KHV-TNFR-R which is the complementary strand of the sequence from 7859 to 7878
  • the target DNA was amplified by PCR using the downstream primer and the KHV genome as a saddle, and the nucleotide sequence of the obtained DNA was confirmed.
  • Taq DNA polymerase manufactured by Takara and the 10-fold concentrated reaction solution and 10-fold concentrated dNTP solution attached to the enzyme were used so as to achieve a 1-fold concentration. The reaction solution was adjusted to 50 microliters.
  • PCR was carried out using the above-mentioned PCR primers and a KHV genome as a saddle. PCR conditions were 30 cycles at 95 ° C for 30 seconds, 55 ° C for 30 seconds, and 72 ° C for 30 seconds.
  • the molecular weight of the amplified DNA fragment was measured by performing electrophoresis for 1 hour at 80 mA in TBE buffer using a 0.8% agarose gel. The detection and molecular weight of the amplified DNA fragment were measured as relative mobility with respect to a commercially available lOObp ladder. The DNA fragment was detected by staining agarose gel in TBE buffer containing bromide zyme (: g / mL) and then observing fluorescence under ultraviolet irradiation.
  • the base sequence of the obtained DNA fragment was determined by the dideoxy method using the aforementioned thermostable DNA synthase. As a result, as shown in SEQ ID NO: 5 in the sequence listing, a DNA fragment having a base sequence length of 190 bp was obtained.
  • KHV disease pathogen genome position KHV — GT—F a sequence present from positions 15996 to 16015, and KH V -GT-R, a complementary chain of the sequences present from positions 16141 to 16160, as upstream primers
  • the gene was amplified by PCR, and the base sequence of the obtained DNA was determined. Thereafter, the same procedure as in Example 1 was performed to obtain a DNA fragment having a base sequence length of 165 bp described in SEQ ID NO: 6 in the Sequence Listing.
  • Fig. 1 shows the results of electrophoresis of the PCR amplification products.
  • each of the KHVs having different separation areas like the existing primers, formed distinct DNA bands in the molecular weight portions determined on electrophoresis, and their genomes were used. The presence of
  • Fig. 2 shows an electrophoresis photograph of the PCR amplification product.
  • Both the primers used in Examples 2 and 3 have the ability to form a clear DNA band in the molecular weight part determined by electrophoresis, as in the case of existing primers.
  • the KHV genome can be detected below the amount of lOOpg.
  • none of the primers in the present invention revealed a distinct band due to PCR-amplified DNA with the KHV genome lOpg. That is, it has been clarified that all of the primers obtained in the present invention have a detection sensitivity of KHV genome 100 times that of the previously reported primers, and greatly improve the diagnosis technique of KHV disease.
  • Example 7 shows an electrophoresis photograph of the PCR amplification product.
  • PCR was performed on the DNA extracted from the repulsive force of three caries infected with KHV. KHV was detected with each primer set. For control, KHV genomic DNA isolated in Japan was used. Each PCR was performed in the same manner as in Example 2. Koi's repulsive DNA is extracted from the “Fish DNA—Molecular Genetic Approach” Chapter 2 Gene Analysis (Ikuo Kanno); Hoshiseisha Koseikaku (issued June 10, 1997) It was performed by the method described in 1.
  • Fig. 5 shows the results of electrophoresis of the PCR amplification products.
  • a distinct DNA band specific to KHV was formed on electrophoresis, and a non-specific DNA band was not formed.
  • non-specific DNA bands were formed in addition to KHV-specific DNA bands in the DNA of 3 carp pupae infected with KHV. That is, it has been clarified that the primers obtained in the present invention have excellent detection accuracy of the KHV genome and greatly improve the diagnostic technology for KHV disease compared to the previously reported primers. It was.
  • the koi herpes virus gene can be detected with high sensitivity, high accuracy and speed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

It is intended to provide: a primer set for detecting Koi herpes virus whereby Koi herpes virus infecting carp can be more accurately and quickly detected and identified; a probe for detecting Koi herpes virus; and a method of detecting Koi herpes virus by using the above-described primer set and probe. By using a primer set for detecting Koi herpes virus (KHV) characterized by having a first DNA primer which contains an oligonucleotide part having at least 10 bases in the base sequence represented by SEQ ID NO:1 and a second DNA primer which contains an oligonucleotide part having at least 10 bases in the base sequence represented by SEQ ID NO:2, Koi herpes virus can be more accurately and quickly detected and identified.

Description

明 細 書  Specification
コィヘルぺスウィルス (KHV)の検出方法  How to detect koi herpesvirus (KHV)
技術分野  Technical field
[0001] 本発明は、コィに感染するコィヘルぺスウィルス (KHV)の病原体を同定することの できるコィヘルぺスウィルス検出用プライマーセット及びコィヘルぺスウィルス検出用 プローブや、これらプライマーセットやプローブを用いたコィヘルぺスウィルスの検出 方法等に関する。 背景技術  [0001] The present invention relates to a koi herpes virus detection primer set and a koi herpes virus detection probe capable of identifying a pathogen of koi herpes virus (KHV) infecting carp, and a primer set and a probe thereof. The present invention relates to a method for detecting koi herpes virus used. Background art
[0002] コィヘルぺスウィルス病は、コィヘルぺスウィルス (KHV)に感染することによりマゴ ィや-シキゴィに発生する病気で、発病すると行動が緩慢になったり餌を食べなくな る力 目立った外部症状は少なぐ鰓の退色やびらん (ただれ)などが見られ、幼魚か ら成魚までに発生し、死亡率が高いコィの病気である。  [0002] Koi herpesvirus disease is a disease caused by koi herpes virus (KHV) and caused by Magyi and Shikigoi. The external symptoms are small carp fading and erosion (soak), which occurs from juveniles to adults, and is a carp disease with a high mortality rate.
[0003] 前記コィヘルぺスウィルス病は、 1998年 5月にイスラエルにて、最初の発症の報告 がなされた。その後、同じイスラエルにおいて、その年の秋と翌年の春との 2度発症し 、輸出用のコィを含めて約 600トンのコィが死滅した。被害総額は 400万ドルを超え るものであった。その後も世界各国 (イスラエル、英国、ドイツ、オランダ、ベルギー、 米国、インドネシア、台湾)で次々と発症の報告がなされた。  [0003] The first occurrence of the koi herpesvirus disease was reported in Israel in May 1998. Later, in the same Israel, two episodes occurred in the fall of that year and the spring of the following year, and approximately 600 tons of carp including the carp for export were killed. Total damage exceeded $ 4 million. Since then, there have been many reports of onset in countries around the world (Israel, UK, Germany, Netherlands, Belgium, USA, Indonesia, Taiwan).
[0004] わが国においても 2003年(平成 15年) 11月に農林水産省が茨城県の霞ケ浦にお いてコィヘルぺスウィルス病を疑うコィを確認したと発表して以来、青森、山梨、三重 [0004] Even in Japan in 2003, the Ministry of Agriculture, Forestry and Fisheries announced that Koi suspected Koi herpesvirus disease was confirmed in Kasumigaura, Ibaraki Prefecture. Since then, Aomori, Yamanashi, Mie
、岡山、宫崎と各地でコィヘルぺスウィルス病の発生が報告されている。農林水産省 でも感染経路の特定をはじめとして、この病気の拡散防止につ 、て努めて!/、るところ である。 Outbreaks of koi herpesvirus disease have been reported in Okayama and Amagasaki. The Ministry of Agriculture, Forestry and Fisheries is striving to prevent the spread of this disease, including the identification of infection routes!
[0005] 自然界ゃ養殖場でウィルスによる感染症が発生したとき、その原因となる病原体を 同定することは感染症の新たな伝播の阻止あるいは予防 ·治療において極めて重要 である。従来、魚類病原体を含めて一般細菌、ウィルス、力ビ等を同定するに当たつ ては、その形態、生化学的性状、又は免疫学的手法を用いた生物化学的性状の観 察が行われていた。最近、生化学及び分子遺伝学の発展に伴い、その病原体が有 する染色体 DNAや RNA、病原体構成物質や病原体の代謝物による同定'検出も 可能になった。し力しながら、これらの方法は複雑な工程を多数踏まねばならず、多 大な時間を費やすという問題があり、ウィルス病等のように伝播の早い疾患に十分対 応できない欠点があった。 [0005] When an infectious disease caused by a virus occurs in a natural farm, identifying the causative agent is very important in preventing, preventing or treating new transmission of the infectious disease. Conventionally, in order to identify general bacteria, viruses, vigor, etc. including fish pathogens, observation of their morphology, biochemical properties, or biochemical properties using immunological techniques has been performed. It was. Recently, with the development of biochemistry and molecular genetics, the pathogen is Identification and detection by chromosomal DNA and RNA, pathogen constituents and pathogen metabolites are now possible. However, these methods have a problem in that they have to take a lot of complicated steps, spending a lot of time, and cannot cope with diseases that are transmitted quickly such as viral diseases.
[0006] このような事情に鑑みて、最近では各種の病原体に特異的な遺伝子を検出して病 原体を同定する方法が普及している。この方法は、標的となる病原体の遺伝子から 作製した DNAプローブ (一本鎖 DNAを標識ィ匕合物で標識したもの)が、標的となる 病原体の核酸とのみノ、イブリダィズすることを利用するものである。さらに、目的とす る DNAをごく短時間で大量に増幅できる方法が開発されると、上記決定遺伝子の塩 基配列のうち、両末端の一部分をプライマーとして利用することにより、被検試料 (病 原体を含有する生体組織)を用いてウィルス等の病原体を迅速かつ正確に検出'同 定することがでさるよう〖こなる。  [0006] In view of such circumstances, recently, a method for identifying pathogens by detecting genes specific to various pathogens has become widespread. This method utilizes the fact that a DNA probe (single-stranded DNA labeled with a labeling compound) made from the gene of the target pathogen is only hybridized with the nucleic acid of the target pathogen. It is. Furthermore, when a method capable of amplifying the target DNA in large quantities in a very short time has been developed, the test sample (disease) can be obtained by using a part of both ends of the base sequence of the determined gene as a primer. It is possible to detect and identify pathogens such as viruses quickly and accurately using the living body tissue containing the active ingredient).
[0007] ウィルス検出用のプライマーについては、単純へルぺスウィルス I型及び II型の型特 異的検出方法を提供するものであって、化学合成が可能な程度の大きさで、しかも 型別の特異性が減少しな ヽ塩基配列からなる DNAプライマー及びプローブを用い て、 HSVI型又は HSVII型の感染症を、高精度で、迅速に、しかも型特異的に識別 することができ、その結果を診断及び治療に役立てることができる方法 (例えば、特許 文献 1参照。)や、エイズの原因となるヒト免疫不全ウィルス (HIV)の感染を診断する ために使用できる核酸であって、 HIV— 1核酸の増幅及び検出にプライマー及びプ ローブとして使用され得るヌクレオチド配列(例えば、特許文献 2参照。)や、トマト黄 化葉巻病の早期診断のために、その病原ウィルスであるトマト黄ィ匕葉巻ウィルス (TY LCV)を高感度に検出させる方法 (例えば、特許文献 3参照。)や、ソラマメウィルトウ ィルスの RNA又はその塩基配列においてゥラシルがチミンに置き換わった DNAの 一部を含む核酸プライマー、及びソラマメウィルトウィルスの RNAと相補性を有する 核酸の一部を含む核酸プライマーを用いて、ソラマメウィルトウィルスを検出する方法 (例えば、特許文献 4参照。)が知られている。  [0007] As a primer for virus detection, it simply provides type-specific detection methods for herpesvirus type I and type II, which are large enough to allow chemical synthesis, and that By using DNA primers and probes consisting of base sequences that do not reduce other specificity, HSVI or HSVII infections can be identified with high accuracy, speed, and type-specificity. A nucleic acid that can be used for diagnosing a method that can use the results for diagnosis and treatment (see, for example, Patent Document 1) and human immunodeficiency virus (HIV) infection that causes AIDS. (1) Nucleotide sequences that can be used as primers and probes for amplification and detection of nucleic acids (see, for example, Patent Document 2), and for the early diagnosis of tomato yellow leaf curl, its pathogenic virus, tomato yellow A method for detecting a winding virus (TY LCV) with high sensitivity (for example, refer to Patent Document 3), a nucleic acid primer containing a part of a broad bean Wilt virus RNA or a DNA in which uracil is replaced with thymine in the base sequence, And a method for detecting a broad bean virus using a nucleic acid primer containing a part of a nucleic acid having complementarity with RNA of broad bean virus (see, for example, Patent Document 4).
[0008] また、魚類のウィルス検出用プライマーに関しては、イリドウィルスのような魚類病原 ウィルスを用いた、ウィルス種間で保存されて ヽるリボヌクレオチドレダクターゼ遺伝 子の中で保存性の高い領域のアミノ酸配列に対応する塩基配列で設計した混合プ ライマーを用いて病原ウィルス遺伝子のクローニングをした後、得られた DNA中の魚 病診断に適用できる特異性の高!、塩基配列で混合プライマーを設計し、それを用い て魚病病原イリドウィルスを迅速に診断する方法 (例えば、特許文献 5参照。)が提案 されている。また、 PCR法による 292bpの長さを持つ DNAを検出するコィヘルぺス ウィルスの検出方法 (例えば、非特許文献 1参照。)も報告されているが、検出感度及 び精度の点で問題が指摘されて 、る。 [0008] In addition, with regard to fish virus detection primers, ribonucleotide reductase inheritance that is preserved among virus species using fish pathogenic viruses such as iridoviruses. After cloning a pathogenic virus gene using a mixed primer designed with a nucleotide sequence corresponding to the amino acid sequence of a highly conserved region in the offspring, the specificity of the obtained DNA in the obtained DNA can be applied to fish disease diagnosis. Highly, a method of rapidly diagnosing a fish pathogenic iridovirus using a mixed primer designed with a nucleotide sequence has been proposed (for example, see Patent Document 5). In addition, a detection method for koi herpesvirus that detects DNA with a length of 292 bp by PCR (for example, see Non-Patent Document 1) has been reported, but problems have been pointed out in terms of detection sensitivity and accuracy. It has been.
[0009] 特許文献 1 :特開平 5— 56800号公報 Patent Document 1: Japanese Patent Laid-Open No. 5-56800
特許文献 2 :特表 2001—512701号公報  Patent Document 2: Japanese Patent Publication No. 2001-512701
特許文献 3:特開 2004— 215520号公報  Patent Document 3: Japanese Patent Application Laid-Open No. 2004-215520
特許文献 4:特開平 11— 313679号公報  Patent Document 4: Japanese Patent Laid-Open No. 11-313679
特許文献 5:特開平 7— 284399号公報  Patent Document 5: Japanese Patent Laid-Open No. 7-284399
非特許文献 l :Yuasa,K. et. al. (2005) Fish Pathology 40(1):37- 39.  Non-patent literature l: Yuasa, K. et.al. (2005) Fish Pathology 40 (1): 37-39.
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0010] コィヘルぺスウィルス病は致死率も高く、コィヘルぺスウィルス病により、養殖コィの みならず湖沼に生息する自然界のコィにまで甚大な被害が及んでおり、より正確で 迅速に検出できる方法の開発が切望されている。本発明の課題は、コィに感染する コィヘルぺスウィルスをより正確で迅速に検出.同定することのできるコィヘルぺスゥ ィルス検出用プライマーセット及びコィヘルぺスウィルス検出用プローブや、これらプ ライマーセットやプローブを用いたコィヘルぺスウィルスの検出方法を提供することに ある。 [0010] Koi herpesvirus disease has a high fatality rate. Koi herpes virus disease has caused enormous damage not only to farmed carp but also to natural carp inhabiting lakes. The development of a possible method is eagerly desired. An object of the present invention is to provide a primer set for detecting koi herpes virus, a probe for detecting koi herpes virus, a probe for detecting koi herpes virus, a primer set for detecting koi herpes virus, a primer set of these, An object of the present invention is to provide a method for detecting koi herpesvirus using a probe.
課題を解決するための手段  Means for solving the problem
[0011] 本発明者らは、上記課題を解決するため鋭意研究し、 日本、アメリカ、イスラエル、 インドネシアの各コィヘルぺスウィルス遺伝子の全塩基配列を決定し、各コィヘルべ スウィルス遺伝子レベルでの相同性が約 99%、アミノ酸レベルでの相同性が約 100 %であることを確認した。次に、解明した全塩基配列のうち、コィヘルぺスウィルス病 原体に特異的な繰り返し配列部分に着目し、既知の真核生物やウィルスなど異なる と想定される 150から 200bp程度で、かつ塩基 C及び Gの構成比率が 65%前後を超 えない配列部分を探索し、 日本、アメリカ、イスラエル、インドネシアの各コィヘルぺス ウィルス遺伝子に特異的で、よく保存されて!、る配列番号 5及び 6に記載した 2つの 領域を選定し、カゝかる領域を標的としたコィヘルぺスウィルス検出用プライマーセット ゃコィヘルぺスウィルス検出用プローブを用いると、コィヘルぺスウィルスをより正確 で迅速に検出'同定することができることを見い出し、本発明を完成するに至った。 [0011] In order to solve the above problems, the present inventors have intensively studied, determined the entire base sequences of koi herpesvirus genes in Japan, the United States, Israel, and Indonesia, and at the level of each koi herpesvirus gene. It was confirmed that the homology was about 99% and the homology at the amino acid level was about 100%. Next, among the elucidated all nucleotide sequences, paying attention to the repetitive sequence portion specific to the koi herpesvirus pathogen, the known eukaryotes and viruses differ. Search for a sequence that is assumed to be about 150 to 200 bp and the composition ratio of bases C and G does not exceed about 65%, and is specific for koi herpesvirus genes in Japan, the United States, Israel, and Indonesia. Well conserved! Select two regions described in SEQ ID NOs: 5 and 6, and use a probe for detecting koi herpes virus that targets the covered region using a probe for detecting koi herpes virus. The present inventors have found that koi herpesvirus can be detected and identified more accurately and quickly, and the present invention has been completed.
[0012] すなわち本発明は、(1)配列表における配列番号 1に示される塩基配列の少なくと も 10塩基のオリゴヌクレオチド部分を含有する第 1の DNAプライマーと、配列表にお ける配列番号 2に示される塩基配列の少なくとも 10塩基のオリゴヌクレオチド部分を 含有する第 2の DNAプライマーとを備えたことを特徴とするコィヘルぺスウィルス (K HV)検出用プライマーセットや、(2)配列表における配列番号 3に示される塩基配列 の少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 1の DNAプライマーと、 配列表における配列番号 4に示される塩基配列の少なくとも 10塩基のオリゴヌクレオ チド部分を含有する第 2の DNAプライマーとを備えたことを特徴とするコィヘルぺス ウィルス (KHV)検出用プライマーセットや、(3)上記(1)又は(2)に記載のコィヘル ぺスウィルス(KHV)検出用プライマーセットを用いて、被検試料中のコィヘルぺスゥ ィルス (KHV)遺伝子を増幅することを特徴とするコィヘルぺスウィルス (KHV)の検 出方法や、(4)配列表における配列番号 5に示される塩基配列又はその相補配列の 少なくとも 10塩基の標識ィ匕オリゴヌクレオチド部分を備えたことを特徴とするコィヘル ぺスウィルス (KHV)検出用プローブや、(5)配列表における配列番号 6に示される 塩基配列又はその相補配列の少なくとも 10塩基の標識ィ匕オリゴヌクレオチド部分を 備えたことを特徴とするコィヘルぺスウィルス (KHV)検出用プローブや、(6)上記 (4 )又は(5)に記載のコィヘルぺスウィルス (KHV)検出用プローブと被検試料とを、ハ イブリダィゼーシヨンが可能な条件下でインキュベートすることを特徴とするコィヘル ぺスウィルス (KHV)の検出方法に関する。 [0012] That is, the present invention relates to (1) a first DNA primer containing an oligonucleotide part of at least 10 bases in the base sequence shown in SEQ ID NO: 1 in the sequence listing, and SEQ ID NO: 2 in the sequence listing. A primer set for detecting koi herpesvirus (KHV), comprising a second DNA primer containing an oligonucleotide portion of at least 10 bases of the base sequence shown in (2) A first DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 3 and a first DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 4 in the sequence listing; A primer set for detection of koi herpesvirus (KHV), characterized by comprising two DNA primers, and (3) the above-mentioned (1) or (2) A detection method for koi herpesvirus (KHV) characterized by amplifying koi herpesvirus (KHV) gene in a test sample using a primer set for detecting herpes virus (KHV), ( 4) A koherpesvirus (KHV) detection probe comprising a labeled oligonucleotide sequence of at least 10 bases of the nucleotide sequence shown in SEQ ID NO: 5 in the sequence listing or its complementary sequence; A probe for detection of koi herpesvirus (KHV), characterized by comprising at least 10 bases of labeled nucleotide sequence of the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing or its complementary sequence; (6) Incubating the koi herpesvirus (KHV) detection probe according to (4) or (5) above and a test sample under conditions that allow hybridization. The present invention relates to a detection method for koi herpesvirus (KHV).
[0013] また本発明は、(7)配列番号 5又は 6に示される塩基配列若しくはその相補的配列 力 なる DNAや、(8)配列番号 5又は 6に示される塩基配列において、 1若しくは数 個の塩基が欠失、置換若しくは付加された塩基配列からなり、かつプローブとして用 いたとき、コィヘルぺスウィルス(KHV)を検出しうる DNAや、(9)配列番号 5又は 6 に示される塩基配列に相補的な配列力もなる DNAとストリンジヱントな条件下でノ、ィ ブリダィズし、かつプローブとして用いたとき、コィヘルぺスウィルス (KHV)を検出し うる DNAに関する。 [0013] The present invention also relates to (7) DNA having the nucleotide sequence shown in SEQ ID NO: 5 or 6 or a complementary sequence thereof, or (8) one or several nucleotides in the nucleotide sequence shown in SEQ ID NO: 5 or 6. Consisting of a base sequence deleted, substituted, or added, and used as a probe And DNA that can detect koi herpesvirus (KHV) and (9) DNA that has a sequence ability complementary to the nucleotide sequence shown in SEQ ID NO: 5 or 6 under stringent conditions. It also relates to DNA that can detect koi herpesvirus (KHV) when used as a probe.
図面の簡単な説明  Brief Description of Drawings
[0014] [図 1]日本分離株 (KHV-J)、アメリカ分離株 (KHV-A)、イスラエル分離株 (KHV  [0014] [Figure 1] Japanese isolate (KHV-J), American isolate (KHV-A), Israel isolate (KHV)
-I)の KHVゲノムの全長 (bp)と予測された遺伝子数を示す図である。  -I) is a graph showing the total length (bp) of the KHV genome and the predicted number of genes.
[図 2]日本分離株 (KHV-J)、アメリカ分離株 (KHV-A)、イスラエル分離株 (KHV —I)の KHVゲノムの相同性の比較結果を示す図である。  FIG. 2 is a diagram showing the results of comparing the homology of KHV genomes of Japanese isolates (KHV-J), American isolates (KHV-A), and Israel isolates (KHV-I).
[図 3]本発明の KHV検出用プライマーを用いた PCR増幅産物の電気泳動結果を示 す図である。  FIG. 3 is a diagram showing the results of electrophoresis of PCR amplification products using the KHV detection primer of the present invention.
[図 4]本発明の KHV病病原体検出用プライマーを用い、 KHVゲノムの量 (6種類)に 対する PCR増幅産物の電気泳動結果を示す図である。  FIG. 4 is a diagram showing the results of electrophoresis of PCR amplification products for the amount of KHV genome (six types) using the KHV disease pathogen detection primer of the present invention.
[図 5]本発明の KHV病病原体検出用プライマーを用い、 KHVに感染した 3匹のコィ の鰓の DNAに対する PCR増幅産物の電気泳動結果を示す図である。  FIG. 5 is a diagram showing the results of electrophoresis of PCR amplification products for DNA of 3 carp pupae infected with KHV using the KHV disease pathogen detection primer of the present invention.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0015] 本発明のコィヘルぺスウィルス (KHV)検出用プライマーセットとしては、配列表に おける配列番号 1に示される塩基配列の少なくとも 10塩基のオリゴヌクレオチド部分 を含有する第 1の DNAプライマーと、配列表における配列番号 2に示される塩基配 列の少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 2の DNAプライマーと を備えたプライマーセット、あるいは、配列表における配列番号 3に示される塩基配 列の少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 1の DNAプライマーと [0015] As a primer set for detection of koi herpesvirus (KHV) of the present invention, a first DNA primer containing an oligonucleotide portion of at least 10 bases of the base sequence shown in SEQ ID NO: 1 in the sequence listing; A primer set comprising a second DNA primer containing an oligonucleotide part of at least 10 bases of the base sequence shown in SEQ ID NO: 2 in the sequence listing, or of the base sequence shown in SEQ ID NO: 3 in the sequence listing A first DNA primer containing an oligonucleotide portion of at least 10 bases;
、配列表における配列番号 4に示される塩基配列の少なくとも 10塩基のオリゴヌタレ ォチド部分を含有する第 2の DNAプライマーとを備えたプライマーセットであれば特 に制限されず、これらコィヘルぺスウィルス検出用プライマーセットを用いて、被検試 料中のコィヘルぺスウィルス遺伝子を増幅することにより、コィヘルぺスウィルスを検 出することができる。 The primer set is not particularly limited as long as it is a primer set comprising a second DNA primer containing an oligonucleotide at least 10 nucleotides of the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing, and for detecting these koi herpes viruses. By using the primer set to amplify the koi herpesvirus gene in the test sample, koi herpesvirus can be detected.
[0016] 上記少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 1の DNAプライマー や第 2の DNAプライマーとしては、 10〜50塩基のオリゴヌクレオチド部分、より好ま しくは 15〜30塩基のオリゴヌクレオチド部分、中でも 20塩基のオリゴヌクレオチド部 分を含有するプライマーが好ましいが、プライマーの長さとしては、 PCRによる増幅 する DNAにお!/ヽて 1塩基以上離れておればよ!ヽ。 [0016] The first DNA primer containing the oligonucleotide portion of at least 10 bases The second DNA primer is preferably a primer containing an oligonucleotide part of 10 to 50 bases, more preferably an oligonucleotide part of 15 to 30 bases, and more preferably an oligonucleotide part of 20 bases. As a matter of fact, the DNA to be amplified by PCR should be at least one base away!
[0017] また、本発明のコィヘルぺスウィルス (KHV)検出用プローブとしては、配列表にお ける配列番号 5に示される塩基配列(コィヘルぺスウィルスのゲノム 7689— 7878あ る! /、は 280527— 280716の 190bp咅分)又はそのネ目ネ甫酉己歹 IJの少なくとも 10塩基、 好ましくは 20塩基以上の標識ィ匕オリゴヌクレオチド部分を備えたプローブ、あるいは 、配列表における配列番号 6に示される塩基配列(コィヘルぺスウィルスのゲノム 15 996— 16160あるいは 288834— 288998の 165bp部分)又はその相補配列の少 なくとも 10塩基、好ましくは 20塩基以上の標識ィ匕オリゴヌクレオチド部分を備えたプ ローブを有するものであれば特に制限されず、これらコィヘルぺスウィルス検出用プ ローブと被検試料とを、ハイブリダィゼーシヨンが可能な条件下でインキュベートする ことにより、コィヘルぺスウィルスを常法により検出することができる。  [0017] The koi herpesvirus (KHV) detection probe of the present invention includes the nucleotide sequence shown in SEQ ID NO: 5 in the sequence listing (the koi herpes virus genome is 7689-7878! 280527-280716 of 190 bp) or a probe having a labeled oligonucleotide portion of at least 10 bases, preferably 20 bases or more of IJ, or shown in SEQ ID NO: 6 in the sequence listing Probes having a labeled nucleotide sequence of at least 10 bases, preferably 20 bases or more, or a complementary sequence thereof (the 165 bp portion of koi herpesvirus genome 15 996-16160 or 288834-288998) or its complementary sequence The probe is not particularly limited as long as it has a pH, and the koi herpesvirus detection probe and the test sample are incubated under conditions where hybridization is possible. By Tosuru, it can be detected by a conventional method Koiheru Bae scan virus.
[0018] 上記被検試料としては、コィヘルぺスウィルスを含有している疑いのある試料であ れば特に制限されず、例えば、コィのエラ、表皮、肝臓、腎臓などの組織や血液から 常法により抽出した DNA抽出液を具体的に例示することができる。  [0018] The test sample is not particularly limited as long as it is a sample suspected of containing koi herpes virus. For example, it is usually obtained from tissues and blood such as carp era, epidermis, liver, and kidney. A DNA extract extracted by the method can be specifically exemplified.
[0019] 本発明のコィヘルぺスウィルス検出用プライマーセットを用いる本発明のコィヘル ぺスウィルスの検出方法は、被検試料中のコィヘルぺスウィルス遺伝子 DNAの増幅 工程と、コィヘルぺスウィルス遺伝子 DN A検出工程とからなる。遺伝子 DNAの増幅 工程では、ポリメラーゼ連鎖反応 (PCR)法、ループメディエイティッド'アイソサーマ ル'アンプリフィケーシヨン法(LAMP)、アイソサーマル 'アンド'キメリック 'プライマー ィ-シエイテッド ·アンプリフィケーシヨン法 (ICAN)などを用いることができる。  [0019] The method for detecting koi herpesvirus of the present invention using the koi herpes virus detection primer set of the present invention comprises an amplification process of koi herpes virus gene DNA in a test sample, koi herpes virus gene DN A detection process. In the gene DNA amplification process, the polymerase chain reaction (PCR) method, the loop-mediated 'isothermal' amplification method (LAMP), the isothermal 'and'chimeric'primer-cited amplification method ( ICAN) can be used.
[0020] 例えば、 PCR法を利用すると、微量の DNAから、 目的とする DNA領域のみを自動 的に約 100万倍にまで増幅することができる(Science, 239:487-491, 1988)。 PCRで は、増幅させる DNA領域を挟んでセンス鎖に対するプライマー(以下、第 1プライマ 一と!ヽぅことがある)及びアンチセンス鎖に対するプライマー(以下、第 2プライマーと いうことがある)の 2種の DNAプライマーを用いて、被検試料中のコィヘルぺスウィル ス遺伝子 DNAを増幅することができる。上記第 1プライマーや第 2プライマーのそれ ぞれを構成する各塩基は、公知の任意の態様で修飾 (例えば、ピオチン化又は発光 物質によるラベル化)されて 、てもよ 、。 [0020] For example, the PCR method can automatically amplify only the target DNA region up to about 1 million times from a very small amount of DNA (Science, 239: 487-491, 1988). In PCR, a primer for the sense strand (hereinafter sometimes referred to as the first primer) and a primer for the antisense strand (hereinafter sometimes referred to as the second primer) across the DNA region to be amplified. Using various DNA primers, koi herpes will in test samples Gene DNA can be amplified. Each base constituting each of the first primer and the second primer may be modified in any known manner (for example, labeled with piotin or a luminescent substance).
[0021] PCRにおける DNA増幅工程では、第 1プライマー及び第 2プライマーと共に、 DN Aポリメラーゼ、好ましくは耐熱性 DNAポリメラーゼを用いて増幅サイクルを繰り返す 。耐熱性ポリメラーゼとしては、特に 95°Cまでの温度で活性を維持することのできる D NAポリメラーゼ、例えば、巿販の Taqポリメラーゼを用いることが好ましい。第 1プライ マー、第 2プライマー及び DNAポリメラーゼの使用量は、被検試料の種類によって 変化するが、 PCR法による DNA増幅工程を実行することができる範囲で容易に決 定することができる。この混合液は場合により、緩衝液 (例えば、トリス塩酸緩衝液)、 安定化剤 (例えば、ゼラチン)、又は塩類 (例えば、塩化ナトリウム)を含有することが できる。 [0021] In the DNA amplification step in PCR, the amplification cycle is repeated using a DNA polymerase, preferably a heat-resistant DNA polymerase, together with the first primer and the second primer. As the thermostable polymerase, it is preferable to use DNA polymerase capable of maintaining activity at a temperature up to 95 ° C., for example, Taq polymerase available from the market. The amounts used of the first primer, the second primer, and the DNA polymerase vary depending on the type of test sample, but can be easily determined as long as the DNA amplification step by the PCR method can be performed. The mixture can optionally contain a buffer (eg, Tris-HCl buffer), a stabilizer (eg, gelatin), or a salt (eg, sodium chloride).
[0022] 本発明のプライマーセット、 DNAポリメラーゼ及び被検試料を含む混合液を用いて PCRを行う場合の増幅条件としては、例えば、 DNAの変性(約 90〜95°Cで、約 10 秒〜約 2分間)、 1本鎖 DNAと第 1プライマー及び第 2プライマーとのアニーリング (約 37〜70°Cで、約 30秒〜約 3分間)、及び DNAポリメラーゼによる DNA合成(約 65 〜80°Cで、約 30秒〜約 5分間)を好適に挙げることができ、この増幅サイクルを 10〜 60回、特に 20〜40回繰り返すことが好ましい。最終サイクルにおいては、 DNAポリ メラーゼによる DNA合成の加熱時間を約 5〜: LO分間に延長して DNA合成が完全 に行われるようにすることが好まし!/、。被検試料中にコィヘルぺスウィルスが存在する 場合には、増幅サイクル終了後に、コィヘルぺスウィルス由来の DNAが大量に合成 されることになり、この DNAを次の DNA検出工程によって検出する。  [0022] Amplification conditions when PCR is performed using a mixed solution containing the primer set of the present invention, DNA polymerase and test sample are, for example, DNA denaturation (about 90 to 95 ° C, about 10 seconds to about About 2 minutes), annealing of single-stranded DNA with the first and second primers (about 37-70 ° C, about 30 seconds to about 3 minutes), and DNA synthesis with DNA polymerase (about 65-80 ° C) C for about 30 seconds to about 5 minutes) can be preferably mentioned, and this amplification cycle is preferably repeated 10 to 60 times, particularly 20 to 40 times. In the final cycle, it is preferable to extend the DNA synthesis heating time by DNA polymerase to about 5 to: LO minutes to ensure complete DNA synthesis! /. If koi herpesvirus is present in the test sample, a large amount of koi herpesvirus-derived DNA will be synthesized after the amplification cycle, and this DNA will be detected in the next DNA detection step.
[0023] DNA検出工程としては、ゲル電気泳動法及びェチジゥムブロマイド染色を利用す る方法、サザンプロットハイブリッド法、又はジデォキシ法による塩基配列決定法、放 射性標識法などを用いることができる。ゲル電気泳動法を行う場合には、例えば、ァ ガロースゲルを担体としたサブマリーン型電気泳動、又はアクリルアミドを用いたスラ ブ型電気泳動を使用することができる。サザンプロットハイブリッド法、又は in situハイ ブリツド法 を行う場合には、放射性プローブ、非放射性プローブ (例えば、酵素標識プローブ、 ピオチン化プローブ、ジゴキシゲニン化プローブ又は化学発光物質、蛍光物質で標 識したプローブ)を用いることができる。更に、ジデォキシ法による塩基配列決定法を 利用する場合には、蛍光標識を使用した DNAオートシークェンサ一(アプライドバイ オシステムズ社)を用いることができる。 [0023] As the DNA detection step, a method using gel electrophoresis and ethidium bromide staining, a Southern plot hybrid method, a base sequencing method by the dideoxy method, a radioactive labeling method, or the like may be used. it can. In the case of performing gel electrophoresis, for example, submarine type electrophoresis using an agarose gel as a carrier or slab type electrophoresis using acrylamide can be used. Southern plot hybrid method or in situ hybrid method In the case of conducting, a radioactive probe or a non-radioactive probe (for example, an enzyme-labeled probe, a piotinylated probe, a digoxigenated probe, a chemiluminescent substance, or a probe labeled with a fluorescent substance) can be used. Furthermore, when using the base sequence determination method by the dideoxy method, a DNA autosequencer (Applied Biosystems) using a fluorescent label can be used.
[0024] 上記増幅工程で用いる第 1プライマーと第 2プライマーとの組み合わせとしては、配 列番号 1に示される塩基配列(acagtgtccgacttgtgcga)力 なるオリゴヌクレオチド( 以下、 KHV—TNFR— Fということがある)と配列番号 2に示される塩基配列(tggtgc ccacatgtgcgttg)からなるオリゴヌクレオチド(以下、 KHV— TNFR— Rということが ある)との組み合わせ(以下、 KHV— TNFRプライマーセットということがある)や、配 列番号 3に示される塩基配列(gacactgaacatgaacactg)力 なるオリゴヌクレオチド( 以下、 KHV—GT—Fということがある)と配列番号 4に示される塩基配列(gaatccat ccccatcacccg)力もなるオリゴヌクレオチド(以下、 KHV— GT— Rということがある) との組み合わせ(以下、 KHV— GTプライマーセットということがある)を好適に例示 することができ、これらの組み合わせのいずれ力 1種を単独で用いる力 又は 2種を 同時に用いることもできる。  [0024] As a combination of the first primer and the second primer used in the amplification step, an oligonucleotide having a base sequence (acagtgtccgacttgtgcga) shown in SEQ ID NO: 1 (hereinafter sometimes referred to as KHV-TNFR-F) In combination with an oligonucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 2 (tggtgc ccacatgtgcgttg) (hereinafter sometimes referred to as KHV—TNFR—R) (hereinafter sometimes referred to as KHV—TNFR primer set) The oligonucleotide having the base sequence shown in No. 3 (gacactgaacatgaacactg) (hereinafter sometimes referred to as KHV-GT-F) and the oligonucleotide having the base sequence shown in SEQ ID No. 4 (gaatccat ccccatcacccg) (hereinafter referred to as KHV-GT) -Sometimes referred to as R) (hereinafter referred to as KHV-GT primer set). It is also possible to use force or two using any force one combination of these alone simultaneously.
[0025] 上記 KHV— TNFR— Fは、コィヘルぺスウィルスのゲノム 7689— 7708あるいは 2 80527— 280546に存在し、 KHV— TNFR— Rは、コィヘルぺスウィルスのゲノム 7 859— 7878ある!/ヽ ίま 280697— 280716【こ存在する酉己歹 [Jのネ目ネ甫鎖であり、これら HV— TNFRプライマーセットを用いると、配列番号 5に示される 190bpの塩基配列 力もなる DNAを増幅することができる。また、上記 KHV— GT— Fは、コィヘルぺスゥ イノレスのゲノム 15996— 16015ある!/ヽ ίま 288834— 288853【こ存在し、 KHV—GT — Rは、コィヘルぺスウィルスのゲノム 16141— 16160あるいは 288979— 288998 に存在する配列の相補鎖であり、これら KHV— GTプライマーセットを用いると、配列 番号 6に示される 165bpの塩基配列力 なる DNAを増幅することができる。これら HV— TNFRプライマーセットや KHV— GTプライマーセットを用いると、コィへノレべ スウィルスのゲノム 7689— 7878あるいは 280527— 280716の 190bp部分ゃゲノ ム 15996— 16160ある!/ヽ ίま 288834— 288998の 165bp咅分を、短時 の内【こ特 異的に大量に増幅することができるので、被検試料中におけるコィヘルぺスウィルス 遺伝子 DNAの存在を特異的に検出することができる。 [0025] The KHV-TNFR-F is present in the koi herpesvirus genome 7689-7708 or 2 80527-280546, and the KHV-TNFR-R is the koi herpesvirus genome 7 859-7878! / ヽ280697— 280716 [This is a double strand of J. Using these HV-TNFR primer sets, it is possible to amplify DNA with a nucleotide sequence of 190 bp shown in SEQ ID NO: 5. Can do. In addition, the above KHV-GT-F has the genome of koi herpes innores 15996-16015! / ヽ ίma 288834-288853 [KHV-GT-R is the genome of koi herpesvirus 16141-16160 or It is a complementary strand of the sequence present in 288979-288998. By using these KHV-GT primer sets, a DNA having a base sequence of 165 bp shown in SEQ ID NO: 6 can be amplified. With these HV-TNFR primer sets and KHV-GT primer sets, the 190bp portion of the Coherenovirus virus 7689-7878 or 280527-280716 is the genome 15996-16160! / ヽ ίma 288834-288998 165bp apportionment within a short time Since it can be amplified in large amounts, it is possible to specifically detect the presence of koi herpesvirus gene DNA in the test sample.
[0026] 本発明の第 1プライマーや第 2プライマーは、通常の DNA自動合成機 (例えばアブ ライドバイオシステム社製)を用いて、公知の DNA合成法 (例えばホスホアミダイト法 )によって調製することができる。  [0026] The first primer and the second primer of the present invention can be prepared by a known DNA synthesis method (for example, phosphoramidite method) using an ordinary automatic DNA synthesizer (for example, manufactured by Ablide Biosystems). it can.
[0027] 本発明のコィヘルぺスウィルス検出用プローブを用 、る本発明のコィヘルぺスウイ ルスの検出方法は、被検試料中のコィヘルぺスウィルス遺伝子 DNAに標識化され て ヽる本発明のコィヘルぺスウィルス検出用プローブをノヽイブリダィズさせ、プローブ に結合されている標識物質を検出することにより行うことができ、被検試料として、コィ ヘルぺスウィルスを含有している疑いのある試料から常法により抽出した DNA抽出 液をそのまま使用することもできる力 PCR法により増幅されたコィヘルぺスウィルス 遺伝子 DNAを使用することもできる。  [0027] The method for detecting koi herpesvirus of the present invention using the probe for detecting koi herpes virus of the present invention is the method of detecting the koi herpes virus gene DNA in the test sample. A probe for detecting koi herpesvirus can be detected by detecting the labeling substance bound to the probe. From the sample suspected of containing koi herpes virus, A DNA extract extracted by a conventional method can be used as it is. Koi herpesvirus gene DNA amplified by the PCR method can also be used.
[0028] 上記標識物質としては、酵素、蛍光物質、化学発光物質、放射性同位体、ピオチン 、アビジン等を挙げることができ、具体的には、ペルォキシダーゼ(例えば、 horseradi sh peroxidase)、ァノレカリフォスファターゼ、 β—D ガラクトシダーゼ、グルコースォ キシダーゼ、グルコース 6—ホスフェートデヒドロゲナーゼ、アルコール脱水素酵素 、リンゴ酸脱水素酵素、ぺ-シリナーゼ、カタラーゼ、アポグルコースォキシダーゼ、 ゥレアーゼ、ルシフェラーゼ若しくはアセチルコリンエステラーゼ等の酵素、フルォレ スセインイソチオシァネート、フィコピリタンパク、希土類金属キレート、ダンシルクロラ イド若しくはテトラメチルローダミンイソチオシァネート等の蛍光物質、 3H、 "C、 125 I若しくは1311等の放射性同位体、ピオチン、アビジン、又は化学発光物質を例示する ことができる。 [0028] Examples of the labeling substance include enzymes, fluorescent substances, chemiluminescent substances, radioisotopes, piotin, avidin, and the like. Specifically, peroxidase (for example, horseradish peroxidase), anorecalphosphatase, etc. , Β-D galactosidase, glucose oxidase, glucose 6-phosphate dehydrogenase, alcohol dehydrogenase, malate dehydrogenase, percylinase, catalase, apoglucose oxidase, urease, luciferase or acetylcholinesterase Fluorescent substances such as cein isothiocyanate, phycopyriprotein, rare earth metal chelates, dansyl chloride or tetramethylrhodamine isothiocyanate, radioactive isotopes such as 3 H, “C, 125 I or 131 1, piotin, Examples of vidin or chemiluminescent materials can be given.
[0029] 本発明の DNAとしては、配列番号 5又は 6に示される塩基配列若しくはその相補 的配列からなる DNAや、配列番号 5又は 6に示される塩基配列において、 1若しくは 数個の塩基が欠失、置換若しくは付加された塩基配列からなり、かつプローブとして 用いたとき、コィヘルぺスウィルスを検出しうる DNAや、配列番号 5又は 6に示される 塩基配列に相補的な配列力もなる DNAとストリンジェントな条件下でノヽイブリダィズ し、かつプローブとして用いたとき、コィヘルぺスウィルスを検出しうる DNAであれば 特に制限されるものでなぐ上記「1若しくは数個の塩基が欠失、置換若しくは付加さ れた塩基配列」とは、例えば 1〜20個、好ましくは 1〜15個、より好ましくは 1〜: LO個 、さらに好ましくは 1〜5個の任意の数の塩基が欠失、置換若しくは付加された塩基 配列を意味する。 [0029] The DNA of the present invention includes a DNA consisting of the base sequence shown in SEQ ID NO: 5 or 6 or a complementary sequence thereof, or the base sequence shown in SEQ ID NO: 5 or 6, lacking one or several bases. A DNA and a string consisting of a deleted, substituted or added nucleotide sequence and capable of detecting koi herpesvirus when used as a probe, or a DNA having a complementary sequence to the nucleotide sequence shown in SEQ ID NO: 5 or 6. DNA that can detect koi herpesvirus when it is hybridized under gentle conditions and used as a probe The above-mentioned “base sequence in which one or several bases are deleted, substituted or added” is not particularly limited, for example, 1 to 20, preferably 1 to 15, more preferably 1 to: LO means a base sequence in which any number of bases, more preferably 1 to 5, is deleted, substituted or added.
[0030] 例えば、これら 1若しくは数個の塩基が欠失、置換若しくは付加された塩基配列か らなる DNA (変異 DNA)は、化学合成、遺伝子工学的手法、突然変異誘発などの 当業者に既知の任意の方法により作製することもできる。具体的には、配列番号 5又 は 6に示される塩基配列力 なる DNAに対し、変異原となる薬剤と接触作用させる方 法、紫外線を照射する方法、遺伝子工学的な手法等を用いて、これら DNAに変異 を導入することにより、変異 DNAを取得することができる。遺伝子工学的手法の一つ である部位特異的変異誘発法は特定の位置に特定の変異を導入できる手法である こと力り 用であり、 Molecular Cloning: A laboratory Mannuai,3rd Ed.,し old Spring Harbor Laboratory, Cold Spring Harbor, NY., 2001. (以後"モレキュラークロー-ング ¾¾3版 と略す)、 Current Protocols in Molecular Biology, Supplement 1〜38, John Wiley & Sons (1987-1997)等に記載の方法に準じて行うことができる。この変異 DNA を適切な発現系を用いて発現させることにより、 1若しくは数個のアミノ酸が欠失、置 換若しくは付加されたアミノ酸配列力もなるタンパク質を得ることができる。  [0030] For example, DNA (mutant DNA) consisting of a base sequence in which one or several bases are deleted, substituted or added is known to those skilled in the art such as chemical synthesis, genetic engineering techniques, mutagenesis, etc. It can also be produced by any method. Specifically, the DNA having the nucleotide sequence shown in SEQ ID NO: 5 or 6 can be contacted with a mutagen drug, irradiated with ultraviolet light, genetically engineered, etc. Mutant DNA can be obtained by introducing mutations into these DNAs. Site-specific mutagenesis, one of the genetic engineering methods, is a technique that can introduce a specific mutation at a specific position. Molecular Cloning: A laboratory Mannuai, 3rd Ed., Old Spring Harbor Laboratory, Cold Spring Harbor, NY., 2001. (hereinafter abbreviated as "Molecular Cloning ¾¾3"), Current Protocols in Molecular Biology, Supplement 1-38, John Wiley & Sons (1987-1997), etc. By expressing this mutant DNA using an appropriate expression system, it is possible to obtain a protein having an amino acid sequence ability in which one or several amino acids have been deleted, replaced, or added. .
[0031] 上記「ストリンジェントな条件下でハイブリダィズする塩基配列」とは、 DNA又は RN Aなどの核酸をプローブとして使用し、コロニ一'ハイブリダィゼーシヨン法、プラーク ハイブリダィゼーシヨン法、あるいはサザンブロットハイブリダィゼーシヨン法等を用い ることにより得られる塩基配列を意味し、具体的には、コロニーあるいはプラーク由来 の DNA又は該 DNAの断片を固定化したフィルターを用いて、 0. 7〜1. 0Mの NaC 1存在下、 65°Cでノヽイブリダィゼーシヨンを行った後、 0. 1〜2倍程度の SSC溶液(1 倍濃度の SSC溶液の組成は、 150mM塩ィ匕ナトリウム、 15mMクェン酸ナトリウム)を 用い、 65°C条件下でフィルターを洗浄することにより同定できる DNAをあげることが できる。ハイブリダィゼーシヨンは、モレキュラークローユング第 3版等に記載されてい る方法に準じて行うことができる。  [0031] The above-mentioned "base sequence that hybridizes under stringent conditions" means using a nucleic acid such as DNA or RNA as a probe, colony 'hybridization method, plaque hybridization method, Alternatively, it means a base sequence obtained by using the Southern blot hybridization method, etc., specifically, using a filter on which colony or plaque-derived DNA or a fragment of the DNA is immobilized. After performing hybridization at 65 ° C in the presence of 7 to 1.0 M NaC 1, 0.1 to 2 times the SSC solution (the composition of the SSC solution with 1 concentration is 150 mM salt solution) DNA that can be identified can be raised by washing the filter at 65 ° C with sodium chloride (15 mM sodium citrate). Hybridization can be carried out according to the method described in Molecular Cloning 3rd edition.
[0032] すなわち、ストリジェントな条件下とは、いわゆる特異的なハイブリッドが形成され、 非特異的なノ、イブリツドが形成されない条件をいい、具体的には、 50〜70%以上の 相同性を有する DNA同士がハイブリダィズし、それより相同性が低い DNA同士が ハイブリダィズしな 、条件ある 、は通常のサザンハイブリダィゼーシヨンの洗 ヽの条 件である 65°C、 I X SSC、 0. 10/0SDS、又 ίま 0. I X SSC、 0. 10/0SDSにネ目当する 塩濃度でノ、イブリダィズする条件を挙げることができる。例えば、ストリンジェントな条 件下でハイブリダィズすることができる DNAとしては、プローブとして使用する DNA の塩基配列と一定以上の相同性を有する DNAが挙げることができ、例えば 60%以 上、好ましくは 70%以上、より好ましくは 80%以上、さらに好ましくは 90%以上、特に 好ましくは 95%以上、最も好ましくは 98%以上の相同性を有する DNAを好適に例 示することができる。 [0032] That is, under stringent conditions, so-called specific hybrids are formed, This refers to the conditions under which non-specific antibodies and hybrids are not formed. Specifically, there is a condition that DNAs having 50 to 70% or more homology hybridize and DNAs having lower homology do not hybridize to each other. , value is typically Southern hybrida I See 65 ° C is a condition of washingヽof Chillon, IX SSC, 0. 1 0/ 0 SDS, also ί or 0. IX SSC, to 0. 1 0/0 SDS You can list the conditions for the irididation at the salt concentration. For example, DNA that can be hybridized under stringent conditions includes DNA having a certain degree of homology with the base sequence of the DNA used as a probe, for example, 60% or more, preferably 70%. A DNA having a homology of at least%, more preferably at least 80%, further preferably at least 90%, particularly preferably at least 95%, most preferably at least 98% can be suitably exemplified.
[0033] 本発明の DNAの取得方法や調製方法は特に限定されるものでなぐ本明細書中 に開示した KHV— TNFRプライマーセットや KHV— GTプライマーセットを調製し、 それらを用いて、コィヘルぺスウィルス (KHV)の DNAライブラリーをスクリーニング すること〖こより目的の DNAを単離したり、常法に従って化学合成により調製すること ができる。  [0033] The method for obtaining and preparing the DNA of the present invention is not particularly limited, and the KHV-TNFR primer set and the KHV-GT primer set disclosed in the present specification are prepared, and they are used to produce a koihelpe. Screening the DNA library of the virus (KHV) The target DNA can be isolated from this or prepared by chemical synthesis according to conventional methods.
[0034] 以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこ れらの例示に限定されるものではない。実験方法については別段で記載するもの以 外は、モレキュラークローユング第 3版に記載の方法に準じて行った。また、下記の用 語については略号を使用した。  Hereinafter, the present invention will be described more specifically with reference to examples. However, the technical scope of the present invention is not limited to these examples. The experimental methods were the same as those described in Molecular Cloning 3rd edition, except as otherwise described. Abbreviations are used for the following terms.
CTABZNaCl溶液: 0. 7M NaClを含有する 10%セチルトリメチルアンモ-ゥム蓚 酸溶液、トリス:トリスヒドロキシメチルァミノメタン、トリス塩酸:トリスヒドロキシメチルアミ ノメタンを含有し、塩酸で pHを調整したもの、 SDS :ドデシル硫ィ匕ナトリウム、 EDTA: エチレンジァミンテ卜ラ酢酸、 TBE緩衝液: 0. 089M卜ジス、 0. 089M硼酸、 0. 002 M EDTAを含有する液体、 BSA:ゥシ血清アルブミン、 TE : 10mMトリス塩酸(pH8 . 0)、 ImM EDTA (pH8. 0)を含有する溶液、 dATP :デォキシアデノシン三リン酸 、 dCTP :デォキシシトシン三リン酸、 dGTP :デォキシグァニン三リン酸、 dTTP :デォ キシチミン三リン酸、 Triton X— 100 :ポリオキシエチレン(10)ォクチルフエ-ルェ ーテノレ。 実施例 1 CTABZNaCl solution: 10% cetyltrimethylammonium oxalic acid solution containing 0.7M NaCl, Tris: trishydroxymethylaminomethane, trishydrochloric acid: trishydroxymethylaminomethane, pH adjusted with hydrochloric acid , SDS: sodium dodecyl sulfate, EDTA: ethylenediamine tetraacetic acid, TBE buffer: 0.089M bis, 0.089M boric acid, liquid containing 0.002M EDTA, BSA: sushi serum albumin TE: 10 mM Tris-HCl (pH 8.0), ImM EDTA (pH 8.0) -containing solution, dATP: Deoxyadenosine triphosphate, dCTP: Deoxycytosine triphosphate, dGTP: Deoxyguanine triphosphate, dTTP: Deoxythymine triphosphate, Triton X-100: Polyoxyethylene (10) octylphenolatere. Example 1
[0035] 日本、アメリカ及びイスラエルでコィより分離された KHV、すなわち日本分離株 (D DBJァクセッション番号; AP008984)、アメリカ分離株(DDBJァクセッション番号; D Q657948)及びイスラエル分離株(DDBJァクセッション番号; DQ 177346)の全ゲ ノム配列を決定した。図 1にこれら KHVゲノムの全長 (bp)と予測された遺伝子数を 示し、図 2にこれら KHVゲノムの相同性の比較結果を示す。これら KHVゲノム配列 より下記の 2セットの PCRプライマーを作製した。また、各プライマーの日本分離株( KHV-J)のゲノムにおける位置を示す。  [0035] KHV isolated from carp in Japan, USA and Israel, namely Japanese isolate (D DBJ accession number; AP008984), American isolate (DDBJ accession number; D Q657948) and Israel isolate (DDBJ The entire genomic sequence of the accession number; DQ 177346) was determined. Figure 1 shows the total length (bp) of these KHV genomes and the predicted number of genes, and Figure 2 shows the results of comparing the homology of these KHV genomes. The following 2 sets of PCR primers were prepared from these KHV genome sequences. In addition, the position of each primer in the genome of the Japanese isolate (KHV-J) is shown.
[0036] 1. KHV—TNFRプライマー  [0036] 1. KHV—TNFR primer
KHV― TNFR— F: 5 ― acagtgtccgacttgtgcga―  KHV― TNFR― F: 5 ― acagtgtccgacttgtgcga―
(ゲノムの位置: 7689- 7708, 280527- 280546)  (Genome position: 7689-7708, 280527-280546)
KHV - TNFR— R: 5,— tggtgcccacatgtgcgttg - 3,  KHV-TNFR— R: 5, — tggtgcccacatgtgcgttg-3,
(ゲノムの位置: 7859- 7878, 280697- 280716)  (Genome position: 7859-7878, 280697-280716)
[0037] KHV— TNFRプライマーにより下記の配列 190bpが増幅される。下線はプライマ 一配列を示した。  [0037] The following sequence 190 bp is amplified by the KHV—TNFR primer. The underline indicates the primer sequence.
Figure imgf000013_0001
Figure imgf000013_0001
AC ATGTGGGC ACC A - 3  AC ATGTGGGC ACC A-3
[0038] 2. KHV— GTプライマー [0038] 2. KHV—GT primer
ir V― Gl— : 5 ― gacactgaacatgaacactg― 3  ir V― Gl―: 5 ― gacactgaacatgaacactg― 3
(ゲノムの位置: 15996— 16015, 288834- 288853)  (Genome position: 15996- 16015, 288834-288853)
KiriV— l— : 5 ― gaatccatccccatcacccg― 3  KiriV— l—: 5 ― gaatccatccccatcacccg― 3
(ゲノムの位置: 16141— 16160, 288979- 288998)  (Genome position: 16141-16160, 288979-288998)
[0039] KHV— GTプライマーにより下記の配列 165bpが増幅される。下線はプライマー配 列を示した。 GGAATAATACTTACGGGTGATGGGGATGGATTC 3 ' [0039] The following sequence 165 bp is amplified by the KHV-GT primer. The underline indicates the primer sequence. GGAATAATACTTACGGGTGATGGGGATGGATTC 3 '
[0040] KHVのゲノム DNA抽出はモレキュラークローユング第 3版に従い行った。抽出し た DNAは TEバッファ一にて透析し用いた。 [0040] Genomic DNA extraction of KHV was performed according to Molecular Cloning 3rd edition. The extracted DNA was dialyzed against TE buffer.
実施例 2  Example 2
[0041] KHVゲノムの位置 7689力ら 7708番目に存在する配列である前記 KHV—TNF R—Fを上流プライマーとし、同じく 7859から 7878番目に存在する配列の相補鎖で ある KHV— TNFR— Rを下流プライマーとし、 KHVゲノムを铸型として PCR法により 目的 DNAを増幅し、得られた DNAの塩基配列を確認した。増幅にはタカラ社製の TaqDNAポリメラーゼ及び酵素に添付されてくる 10倍濃度反応液及び 10倍濃度 d NTP溶液を 1倍濃度になるように用いた。反応液は 50マイクロリットルになるように調 整した。この溶液を自動温度調節機にかけ、上記の PCRプライマーを用い、 KHVゲ ノムを铸型として PCRを行った。 PCRの条件は、 95°Cで 30秒、 55°Cで 30秒、 72°C で 30秒を 1サイクルとし、 30サイクル行った。  [0041] Position of KHV genome 7689 force et al. The above KHV-TNF R-F, which is the 7708th sequence, is used as an upstream primer, and KHV-TNFR-R, which is the complementary strand of the sequence from 7859 to 7878, is also used. The target DNA was amplified by PCR using the downstream primer and the KHV genome as a saddle, and the nucleotide sequence of the obtained DNA was confirmed. For amplification, Taq DNA polymerase manufactured by Takara and the 10-fold concentrated reaction solution and 10-fold concentrated dNTP solution attached to the enzyme were used so as to achieve a 1-fold concentration. The reaction solution was adjusted to 50 microliters. This solution was subjected to an automatic temperature controller, and PCR was carried out using the above-mentioned PCR primers and a KHV genome as a saddle. PCR conditions were 30 cycles at 95 ° C for 30 seconds, 55 ° C for 30 seconds, and 72 ° C for 30 seconds.
[0042] PCR反応終了後、 0. 8%ァガロースゲルを用い、 TBE緩衝液中にて 80mAで 1時 間の電気泳動を行うことにより、増幅された DNA断片の分子量を測定した。この増幅 DNA断片の検出及び分子量は、市販の lOObpラダーに対する相対移動度として測 定した。 DNA断片の検出は、ァガロースゲルを臭化工チジゥム(: g/mL)含有 T BE緩衝液中で染色した後、紫外線照射過下における蛍光を観察することにより行つ た。  [0042] After completion of the PCR reaction, the molecular weight of the amplified DNA fragment was measured by performing electrophoresis for 1 hour at 80 mA in TBE buffer using a 0.8% agarose gel. The detection and molecular weight of the amplified DNA fragment were measured as relative mobility with respect to a commercially available lOObp ladder. The DNA fragment was detected by staining agarose gel in TBE buffer containing bromide zyme (: g / mL) and then observing fluorescence under ultraviolet irradiation.
[0043] 得られた DNA断片の塩基配列は前述した耐熱性 DNA合成酵素を用 ヽたジデォ キシ法で決定した。その結果は配列表の配列番号 5に記載のとおり、塩基配列の長 さが 190bpの DNA断片を得た。  [0043] The base sequence of the obtained DNA fragment was determined by the dideoxy method using the aforementioned thermostable DNA synthase. As a result, as shown in SEQ ID NO: 5 in the sequence listing, a DNA fragment having a base sequence length of 190 bp was obtained.
実施例 3  Example 3
[0044] KHV病病原体ゲノムの位置 15996から 16015番目に存在する配列である KHV — GT— Fを上流プライマーとし、同じく 16141から 16160番目に存在する配列の相 補鎖である KH V -GT- Rを下流プライマ一とし、 KHV病病原体の種を決定する遺 伝子を PCR法により増幅して、得られた DNAの塩基配列を決定した。以下、実施例 1と同様の操作を行 、配列表の配列番号 6に記載した塩基配列の長さが 165bpの D NA断片を得た。 [0044] KHV disease pathogen genome position KHV — GT—F, a sequence present from positions 15996 to 16015, and KH V -GT-R, a complementary chain of the sequences present from positions 16141 to 16160, as upstream primers To determine the species of KHV disease pathogens The gene was amplified by PCR, and the base sequence of the obtained DNA was determined. Thereafter, the same procedure as in Example 1 was performed to obtain a DNA fragment having a base sequence length of 165 bp described in SEQ ID NO: 6 in the Sequence Listing.
実施例 4  Example 4
[0045] 実施例 2及び 3で得られた二種類の DNA断片の塩基配列について、 KHVゲノム の構成塩基配列の 1部に合致しているかどうかをコンピューター解析ソフト(SDCソフ トウエア)にて比較した。同時に遺伝子配列に関するデータベース (http:〃 www. ncbi. nih.gov/index.html)にアクセスし、これらの塩基配列と同じ部分を持つ真核生物及び ウィルスが存在するか否かにつ!、てもコンピューター解析ソフト(SDCソフトウェア)に て比較解析した。  [0045] The base sequences of the two types of DNA fragments obtained in Examples 2 and 3 were compared by computer analysis software (SDC software) to see if they matched part of the base sequence of the KHV genome. . At the same time, a database on gene sequences (http: 〃 www.ncbi.nih.gov/index.html) is accessed to determine whether or not there are eukaryotes and viruses that have the same parts as these base sequences! A comparative analysis was also performed using computer analysis software (SDC software).
[0046] その結果、得られた DNA断片の塩基配列は ヽずれも KHVゲノム中に存在するこ とが確認され、データベースでの検索結果でも、これらの DNA断片と同じ塩基配列 部分を有する真核生物及びウィルスは存在しな ヽことがわかった。以上のことから、 得られた 190bp及び 165bpの長さを持つ二種類の DNA断片はいずれも KHVを特 異的に検出する DNA配列であるといえる。  [0046] As a result, it was confirmed that the base sequences of the obtained DNA fragments were all present in the KHV genome, and even in the search results in the database, eukaryotics having the same base sequence portion as these DNA fragments were found. It was found that organisms and viruses did not exist. From the above, it can be said that both of the obtained two kinds of DNA fragments having a length of 190 bp and 165 bp are DNA sequences that specifically detect KHV.
実施例 5  Example 5
[0047] 実施例 2及び 3で使用したプライマー、並びに既報の KHV検出用プライマーを使 用して、 日本 C 、アメリカ (Α)、イスラエル (Is)、及びインドネシア (In)で分離された KHVゲノムを铸型とした PCRを行い、 目的の DNA領域を増幅ができるか否かを検 討した。 PCR用の試薬の調整、試験条件及び電気泳動条件は全て実施例 2と同様 とした。既報の KHV検出用プライマーとしては、前記非特許文献 1の Table 1の Corr ectea Sph 1-5 primer setを用いた。  [0047] KHV genomes isolated in Japan C, USA (Α), Israel (Is), and Indonesia (In) using the primers used in Examples 2 and 3 and the previously reported primers for KHV detection PCR was performed using the 铸 type to examine whether the target DNA region could be amplified. Preparation of PCR reagents, test conditions, and electrophoresis conditions were all the same as in Example 2. As a previously reported primer for KHV detection, Correctea Sph 1-5 primer set in Table 1 of Non-Patent Document 1 was used.
[0048] PCR増幅産物の電気泳動結果を図 1に示した。実施例 2及び 3で使用したプライマ 一は、いずれも既存プライマーと同様に分離地域の異なる全ての KHVについて、電 気泳動上でそれぞれ求める分子量部分に明瞭な DNAバンドを形成してそれらのゲ ノムの存在を示した。  [0048] Fig. 1 shows the results of electrophoresis of the PCR amplification products. In each of the primers used in Examples 2 and 3, each of the KHVs having different separation areas, like the existing primers, formed distinct DNA bands in the molecular weight portions determined on electrophoresis, and their genomes were used. The presence of
実施例 6  Example 6
[0049] 実施例 2及び実施例 3で使用したプライマー、並びに既報の KHV検出用プライマ 一を使用して、日本で分離された KHVゲノムに対して PCRを行い、それぞれのプラ イマ一セットによる KHVの検出感度を比較した。それぞれの PCRは実施例 2と同様 にして実施した力 KHVゲノムついては、それぞれの反応液に混合する KHVゲノム DNAの量を 100ng、 10ng、 lng、 100pg、 lOpg及び lpgの 6種類を調整し、 PCR による種決定遺伝子の増幅を試みた。 [0049] Primers used in Example 2 and Example 3, and previously reported primer for KHV detection PCR was performed on KHV genomes isolated in Japan, and the detection sensitivity of KHV by each primer set was compared. Each PCR was performed in the same manner as in Example 2. For KHV genome, the amount of KHV genomic DNA mixed in each reaction solution was adjusted to 6 types: 100 ng, 10 ng, lng, 100 pg, lOpg, and lpg. Attempts to amplify the species-determining gene.
[0050] PCR増幅産物の電気泳動写真を図 2に示した。実施例 2及び 3で使用したプライマ 一は、いずれも既存プライマーと同様に電気泳動上でそれぞれ求める分子量部分に 明瞭な DNAバンドを形成した力 既報プライマーでは KHVゲノムが lOOpgの量以 下では検出できなくなつたのに対し、本発明におけるプライマーのいずれも、 KHVゲ ノム lOpgで PCR増幅 DNAによる明瞭なバンドを出現させた。すなわち、本発明で 得られたプライマーは、いずれも既報プライマーの 100倍の KHVゲノムの検出感度 を有し、 KHV病の診断技術を飛躍的に向上させるものであることが明らかとなつた。 実施例 7 [0050] Fig. 2 shows an electrophoresis photograph of the PCR amplification product. Both the primers used in Examples 2 and 3 have the ability to form a clear DNA band in the molecular weight part determined by electrophoresis, as in the case of existing primers. With the previously reported primers, the KHV genome can be detected below the amount of lOOpg. In contrast, none of the primers in the present invention revealed a distinct band due to PCR-amplified DNA with the KHV genome lOpg. That is, it has been clarified that all of the primers obtained in the present invention have a detection sensitivity of KHV genome 100 times that of the previously reported primers, and greatly improve the diagnosis technique of KHV disease. Example 7
[0051] 実施例 2及び実施例 3で使用したプライマー、並びに既報の KHV検出用プライマ 一を使用して、 KHVに感染した 3匹のコィの鰓力 抽出した DNAに対して PCRを行 い、それぞれのプライマーセットによる KHVの検出を行った。また、コントロールには 日本で分離された KHVゲノム DN Aを用いた。それぞれの PCRは実施例 2と同様に して実施した。コィの鰓力もの DNAの抽出は、「魚類の DNA—分子遺伝学的ァプロ ーチ」 2章 遺伝子の解析法 (廣野育生);株式会社恒星社厚生閣(1997年 6月 10日 発行)に記載された方法により行った。  [0051] Using the primers used in Example 2 and Example 3 and the previously reported KHV detection primer, PCR was performed on the DNA extracted from the repulsive force of three caries infected with KHV. KHV was detected with each primer set. For control, KHV genomic DNA isolated in Japan was used. Each PCR was performed in the same manner as in Example 2. Koi's repulsive DNA is extracted from the “Fish DNA—Molecular Genetic Approach” Chapter 2 Gene Analysis (Ikuo Kanno); Hoshiseisha Koseikaku (issued June 10, 1997) It was performed by the method described in 1.
[0052] PCR増幅産物の電気泳動結果を図 5に示した。実施例 2及び 3で使用したプライマ 一では、いずれも電気泳動上で KHV特異的な明瞭な DNAバンドが形成され、非特 異的 DNAバンドは形成されなカゝつた。これに対して、既報プライマーでは、 KHVに 感染した 3匹のコィの鰓の DNAにおいて、 KHV特異的な DNAバンドに加え、非特 異的 DNAバンドが形成されていた。すなわち、本発明で得られたプライマーは、い ずれも既報プライマーに比べて、 KHVゲノムの優れた検出精度を有し、 KHV病の 診断技術を飛躍的に向上させるものであることが明らかとなった。  [0052] Fig. 5 shows the results of electrophoresis of the PCR amplification products. In each of the primers used in Examples 2 and 3, a distinct DNA band specific to KHV was formed on electrophoresis, and a non-specific DNA band was not formed. On the other hand, in the previously reported primer, non-specific DNA bands were formed in addition to KHV-specific DNA bands in the DNA of 3 carp pupae infected with KHV. That is, it has been clarified that the primers obtained in the present invention have excellent detection accuracy of the KHV genome and greatly improve the diagnostic technology for KHV disease compared to the previously reported primers. It was.
産業上の利用可能性 本発明のコィヘルぺスウィルス検出用プライマーセットゃコィヘルぺスウィルス検出 用プローブを使用することにより、コィヘルぺスウィルス遺伝子を高感度 ·高精度かつ 迅速に検出することができる。 Industrial applicability By using the koi herpes virus detection probe of the present invention, the koi herpes virus gene can be detected with high sensitivity, high accuracy and speed.

Claims

請求の範囲 The scope of the claims
[1] 配列表における配列番号 1に示される塩基配列の少なくとも 10塩基のオリゴヌクレオ チド部分を含有する第 1の DNAプライマーと、配列表における配列番号 2に示される 塩基配列の少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 2の DNAプライ マーとを備えたことを特徴とするコィヘルぺスウィルス (KHV)検出用プライマーセット  [1] A first DNA primer containing at least a 10-nucleotide oligonucleotide portion of the base sequence shown in SEQ ID NO: 1 in the sequence listing, and an oligo of at least 10 bases in the base sequence shown in SEQ ID NO: 2 in the sequence listing Primer set for detection of koi herpesvirus (KHV), characterized by comprising a second DNA primer containing a nucleotide moiety
[2] 配列表における配列番号 3に示される塩基配列の少なくとも 10塩基のオリゴヌクレオ チド部分を含有する第 1の DNAプライマーと、配列表における配列番号 4に示される 塩基配列の少なくとも 10塩基のオリゴヌクレオチド部分を含有する第 2の DNAプライ マーとを備えたことを特徴とするコィヘルぺスウィルス (KHV)検出用プライマーセット [2] A first DNA primer containing an oligonucleotide portion of at least 10 bases of the base sequence shown in SEQ ID NO: 3 in the sequence listing, and an oligo of at least 10 bases in the base sequence shown in SEQ ID NO: 4 in the sequence listing Primer set for detection of koi herpesvirus (KHV), characterized by comprising a second DNA primer containing a nucleotide moiety
[3] 請求項 1又は 2に記載のコィヘルぺスウィルス (KHV)検出用プライマーセットを用い て、被検試料中のコィヘルぺスウィルス (KHV)遺伝子を増幅することを特徴とするコ ィヘルぺスウィルス (KHV)の検出方法。 [3] A koiherpes virus (KHV) gene in a test sample is amplified using the koi herpesvirus (KHV) detection primer set according to claim 1 or 2. Virus (KHV) detection method.
[4] 配列表における配列番号 5に示される塩基配列又はその相補配列の少なくとも 10塩 基の標識ィ匕オリゴヌクレオチド部分を備えたことを特徴とするコィヘルぺスウィルス (K[4] A koi herpesvirus (K) characterized by comprising at least a 10-base labeled oligonucleotide sequence of the nucleotide sequence shown in SEQ ID NO: 5 in the sequence listing or its complementary sequence
HV)検出用プローブ。 HV) Probe for detection.
[5] 配列表における配列番号 6に示される塩基配列又はその相補配列の少なくとも 10塩 基の標識ィ匕オリゴヌクレオチド部分を備えたことを特徴とするコィヘルぺスウィルス (K HV)検出用プローブ。  [5] A probe for koi herpesvirus (KHV) detection, comprising a labeled oligonucleotide sequence having at least 10 bases of the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing or its complementary sequence.
[6] 請求項 4又は 5に記載のコィヘルぺスウィルス (KHV)検出用プローブと被検試料と を、ハイブリダィゼーシヨンが可能な条件下でインキュベートすることを特徴とするコィ ヘルぺスゥイノレス (KHV)の検出方法。  [6] Koi herpes virus-less (KHV) detection probe according to claim 4 and test sample are incubated under conditions allowing hybridization, koi herpes virus (KHV) detection method.
[7] 配列番号 5又は 6に示される塩基配列若しくはその相補的配列力 なる DNA。 [7] A DNA having the nucleotide sequence shown in SEQ ID NO: 5 or 6 or its complementary sequence.
[8] 配列番号 5又は 6に示される塩基配列において、 1若しくは数個の塩基が欠失、置換 若しくは付加された塩基配列カゝらなり、かつプローブとして用いたとき、コィヘルぺス ウィルス (KHV)を検出しうる DNA。 [8] In the base sequence shown in SEQ ID NO: 5 or 6, when one or several bases are deleted, substituted, or added, the base sequence becomes a koi herpes virus (KHV DNA that can detect).
[9] 配列番号 5又は 6に示される塩基配列に相補的な配列力 なる DNAとストリンジ ン トな条件下でハイブリダィズし、かつプローブとして用いたとき、コィヘルぺスウィルス (KHV)を検出しうる DNA。 [9] DNA and stringin having sequence ability complementary to the nucleotide sequence shown in SEQ ID NO: 5 or 6 DNA that can detect koi herpesvirus (KHV) when hybridized under certain conditions and used as a probe.
PCT/JP2007/056614 2006-04-13 2007-03-28 Method of detecting koi herpes virus (khv) WO2007119557A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008510874A JP5315519B2 (en) 2006-04-13 2007-03-28 Koi herpesvirus (KHV) detection method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-111415 2006-04-13
JP2006111415 2006-04-13

Publications (1)

Publication Number Publication Date
WO2007119557A1 true WO2007119557A1 (en) 2007-10-25

Family

ID=38609333

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/056614 WO2007119557A1 (en) 2006-04-13 2007-03-28 Method of detecting koi herpes virus (khv)

Country Status (3)

Country Link
JP (1) JP5315519B2 (en)
TW (1) TW200804604A (en)
WO (1) WO2007119557A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010109874A1 (en) 2009-03-26 2010-09-30 国立大学法人東京海洋大学 Koi herpes virus-specific antibody and antigen thereof
CN109897918A (en) * 2018-08-06 2019-06-18 北京市水产技术推广站 Carp edema virus and Koi herpesvirus dual real-time fluorescence quantitative detecting method

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111004864A (en) * 2018-10-05 2020-04-14 福又达生物科技股份有限公司 Shrimp pathogen detection method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BERCOVIER H. ET AL.: "Cloning of the koi herpesvirus (KHV) gene encoding thymidine kinase and its use for a highly sensitive PCR based diagnosis", BMC MICROBIOLOGY, vol. 5, no. 13, 2005, pages 1 - 9, XP021002610 *
ISHIOKA T. ET AL.: "Detection and sequence analysis of DNA polymerase and major envelope protein genes in koi herpesviruses derived from Cyprinus carpio in Gunma prefecture", JAPAN. VETERINARY MICROBIOLOGY, vol. 110, no. 1-2, 2005, pages 27 - 33, XP005070036 *
SOLIMAN H. ET AL.: "An inexpensive and rapid diagnostic method of Koi Herpesvirus (KHV) infection by loop-mediated isothermal amplification", VIROLOGY JOURNAL, vol. 2, no. 83, 2004, pages 1 - 8, XP021010931 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010109874A1 (en) 2009-03-26 2010-09-30 国立大学法人東京海洋大学 Koi herpes virus-specific antibody and antigen thereof
CN109897918A (en) * 2018-08-06 2019-06-18 北京市水产技术推广站 Carp edema virus and Koi herpesvirus dual real-time fluorescence quantitative detecting method
CN109897918B (en) * 2018-08-06 2022-06-07 北京市水产技术推广站 Double real-time fluorescence quantitative detection method for carp edema virus and koi herpesvirus

Also Published As

Publication number Publication date
TW200804604A (en) 2008-01-16
JPWO2007119557A1 (en) 2009-08-27
JP5315519B2 (en) 2013-10-16

Similar Documents

Publication Publication Date Title
CA2603949C (en) Elite event a5547-127 and methods and kits for identifying such event in biological samples
Magome et al. Single-strand conformation polymorphism analysis of apple stem grooving capillovirus sequence variants
KR101503511B1 (en) Primer set for diagnosing white spot syndrom virus, composition and kit comprising the same
CN104508142A (en) Ion torrent genomic sequencing
Singh et al. A potyvirus in Cymbidium spp. in northern India
KR102555330B1 (en) Composition For Detecting SARS-CoV-2, Kit For Detecting the Same and Method of Detecting SARS-CoV-2 Using the Same
EP1859062A2 (en) Detection of very virulent infectious bursal disease virus
JP5315519B2 (en) Koi herpesvirus (KHV) detection method
JP2010068797A (en) Method for distinguishing biotype in bemisia tabaci
Hill et al. The polymerase chain reaction in molecular and micro-biology
KR102030245B1 (en) Oligonucleotide set for detection of chikungunya virus and uses thereof
US20230167511A1 (en) An ultrasensitive rapid and portable case13d-based diagnostic assay
EP1013775A1 (en) Quantitative polymerase chain reaction using a fluorogenic real-time detection system
KR20060017212A (en) Probe composition and primer mixture for detection of corona virus and method for detecting corona virus using the same
JP2010004878A (en) Method for detecting fungus belonging to genus talaromyces
JP5548389B2 (en) Method for detecting fungi belonging to the genus Bisoclamis
JP5115825B2 (en) Identification marker for rush cultivar "Hinomidori"
JP5548357B2 (en) Method for detecting Aspergillus fumigatus-related bacteria
US20100055703A1 (en) Organism-Specific Hybridizable Nucleic Acid Molecule
US10081832B2 (en) Hyperprimers
KR102499837B1 (en) Composition For Detecting Epizootic Ulcerative Syndrome and Method of Detecting Epizootic Ulcerative Syndrome Using the Same
JP2007000040A (en) Method for detecting b-type hepatitis virus
KR100386135B1 (en) Detection of Nephrotic Hemorrhagic Fever Virus
EP1174521B1 (en) Method for detecting transcribed genomic DNA sequences
JPH07250700A (en) Simple quantification of nucleic acid by competitive pcr process

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07740052

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2008510874

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07740052

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)